Acorah Software Products - Accounts Production 19.4.300 false true false true No description of principal activity 22 November 2024 30 November 2025 30 November 2025 16096468 Dr C Spencer iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16096468 2024-11-21 16096468 2025-11-30 16096468 2024-11-22 2025-11-30 16096468 frs-core:CurrentFinancialInstruments 2025-11-30 16096468 frs-bus:PrivateLimitedCompanyLtd 2024-11-22 2025-11-30 16096468 frs-bus:FilletedAccounts 2024-11-22 2025-11-30 16096468 frs-bus:Micro-entities 2024-11-22 2025-11-30 16096468 frs-bus:AuditExempt-NoAccountantsReport 2024-11-22 2025-11-30 16096468 frs-bus:Director1 2024-11-22 2025-11-30
Registered number: 16096468
CRS Surgery Limited
Unaudited Financial Statements
For the Period 22 November 2024 to 30 November 2025
Nichols & Co (Accountancy) Limited
Contents
Page
Balance Sheet 1
Page 1
Balance Sheet
Registered number: 16096468
30 November 2025
£
Current assets 187,501
Creditors: Amounts Falling Due Within One Year (57,219 )
NET CURRENT ASSETS 130,282
TOTAL ASSETS LESS CURRENT LIABILITIES 130,282
Accruals and deferred income (3,181 )
NET ASSETS 127,101
CAPITAL AND RESERVES 127,101

Notes

1. General Information
CRS Surgery Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16096468 . The registered office is Unit 7, Mulberry Place, Pinnell Road, Eltham, London, SE9 6AR.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr C Spencer
Director
14/09/2026